Alaunos Therapeutics Inc
TCRT
$2.18+5.31%
End of day · as of Oct 16, 2026, 2:01 AM ET
Mkt cap
$5.63M
EV/Sales
848.8
P/E ratio
N/A
FY2025 Revenue
$5,000
EPS (TTM)
$-1.75
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-83520.00%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported TCRT revenue for 2025-12-31 was $5.0K. Net income was -$4.2M. Revenue was down 50.0% from 2024-12-31 to 2025-12-31. TCRT currently screens at market cap $5.6M.
Use this TCRT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TCRT income, balance, and cash tables.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company in the Healthcare sector.
Latest cached Alaunos Therapeutics Inc (TCRT) revenue for Dec 31, 2025 was $5.0K. Net income was -$4.2M. Statements: https://lician.com/financials/tcrt
Alaunos Therapeutics Inc (TCRT) market capitalization is $5.6M on the latest cached snapshot.
Alaunos Therapeutics Inc (TCRT) cached previous close $2.07; day range $2.03 – $2.87; volume 11,391,441. Session quote: https://lician.com/quote/tcrt